share_log

东瑞制药(02348.HK)8月26日董事会考虑及批准中期业绩

Board of Directors of 02348.HK considers and approves interim results on August 26th

Gelonghui Finance ·  Aug 15, 2022 18:50

02348.HK announced that it will hold a board meeting on Friday, August 26, 2022 to, among other things, consider and approve the interim results and publication of the company and its subsidiaries for the six months ended June 3, 2022, as well as consider paying an interim dividend (if any).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment